Here are relevant reports on : brain-health-market
-
Food as Medicine Market By Product Type (Functional Foods, Medical Foods, Nutraceuticals, Personalized Nutrition Products, Therapeutic Food Products), Function (Metabolic Health, Diabetes Management, Cardiovascular Health, Gastrointestinal Health, Immune Health, Other Functions), Ingredient Type, Source, Form, Distribution Channel, Prescription Type (Qualitative), and Region – Global Forecast to 2031
The food as medicine market is estimated at USD 254.15 billion in 2026 and is projected to reach USD 400.81 billion by 2031, at a CAGR of 9.5% from 2026 to 2031 The Key Players Nestlé Health Science (Switzerland), Danone (France), Abbott Nutrition (US), Reckitt Mead Johnson (UK), FrieslandCampina (Netherlands), Herbalife (US), Amway (US), Novonesis (Denmark), Yakult Honsha Co., Ltd. (Japan), Unilever (UK), Otsuka Holdings (Japan), Probi AB (Sweden), Church & Dwight Co., Inc. (US), Meiji Holdings (Japan), and Jamieson Wellness (Canada).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Functional/Brain MRI System Market by Component (Magnet, RF Coil, Cooling System, Shim System), Field Strength (1.5T, 3T, 7T), Application (Brain Tumor, Presurgical Planning, Rehab, Epilepsy), Installed Base & Replacement Rate - Global Forecast to 2031
The global Functional/Brain MRI System market, valued at USD 0.79 billion in 2025, stood at USD 0.85 billion in 2026 and is projected to advance at a resilient CAGR of 8.0% from 2026 to 2031, culminating in a forecasted valuation of USD 1.25 billion by the end of the period. This growth is primarily fueled by the rising demand for high-resolution imaging to study brain activity, particularly in relation to neurological and psychiatric conditions such as stroke, brain tumors, epilepsy, Alzheimer's disease, and other neurological disorders.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Companion Animal Health Market by Animal Type (Dogs, Cats), Product (Vaccines, Pharmaceuticals, Diagnostics), End User (Veterinary Hospitals & Clinics, Diagnostics Laboratories) - Global Forecast to 2027
The companion animal health market is projected to reach USD 26.9 Billion by 2027 from USD 19.2 Billion in 2022 at a CAGR of 6.9% during the forecast period. The growth in this market is mainly attributed to increasing companion animal population, rising demand for pet insurance, growing animal health expenditure, and the increasing number of veterinary practitioners & their rising income level in developed countries. However, increasing pet care costs are expected to hinder market growth to a certain extent.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Essential Oils Market by Product Type, Application (Food & beverages, Cosmetics & Toiletries, Aromatherapy, Home Care, and Health Care), Source (Fruits & Vegetables, Herbs & Spices, Flowers), Method of Extraction and Region - Global Forecast to 2027
The global essential oils market size is projected to reach USD 15.3 billion by 2027, recording a CAGR of 11.8% during the forecast period. This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Cargill, Incorporated (US), DSM (Netherlands), Givaudan (Switzerland), International Flavors & Fragrances Inc. (US), Sensient Technologies Corporation (US), Symrise (Germany), Robertet SA (France), MANE (France), doTERRA (US), NOW Foods (US), Lebermuth, Inc. (US), BIOLANDES (France), Norex Flavours Private Limited (India) and India Essential Oils (India).
- Published: September 2022
- Price: $ 4950
- TOC Available:
-
Womens Health Diagnostics Market by Application (Biopsy, Cervical & Ovarian Cancer Testing, PAP Smear, HPV, TORCH, Prenatal Testing, Hepatitis, Ultrasound, Obstetrics), End User (Hospitals, Clinics, Home Care) & Region - Global Forecast to 2025
The global womens health diagnostics market growth is primed to transition from $25.0 billion in 2020 to $36.6 billion by 2025, showcasing a strong CAGR of 7.9%. The market growth is mainly driven by growing awareness about various health-related disorders, rising incidence of chronic and lifestyle disorders, and the high prevalence of infectious diseases such as HIV and hepatitis in women across the globe.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
Corporate Wellness Solutions Market by Service Offering (HRA, Nutrition, Weight Loss, Fitness, Substance Abuse Management, Employee Assistance Programs, Health Benefits), End User (Organizations (Large, Mid-Sized, SME)) & Region - Global Forecast to 2026
The global corporate wellness solutions market in terms of revenue was estimated to be worth $61.2 billion in 2021 and is poised to reach $94.6 billion by 2026, growing at a CAGR of 9.1% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2021
- Price: $ 4950
- TOC Available:
-
Pet Supplements Market by Functional Application (Skin & Coat, Hips & Joints, Digestive Health, Immune Support), Supplement Type (Multivitamin, Glucosamine, Antioxidants), Pet, Form, Distribution Channel, and Region - Global Forecast to 2029
According to MarketsandMarkets, the global pet supplements market is estimated to be valued at USD XXX.X million in 2024 and is projected to reach USD XXX.X million by 2029, recording a CAGR of X.X%. Key players in this market include ADM (US), Nestlé (Switzerland), Nutramax Laboratories, Inc. (US), Zoetis Services LLC (US), Virbac (France), Zesty Paws (US), These players have adopted strategies of product launches, expansions, agreements/partnerships, and mergers and acquisitions to grow in the market. All key product manufacturers that are part of the pet supplements ecosystem have been considered under the company profiles section.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Prostate Health Market by Disease Indication (Prostate Cancer, PARP Inhibitors, Cytotoxic Drug, Benign Prostate Hyperplasia (BPH), Tamsulosin, 5 Alpha Reductase, Prostatitis, OTC, Prescription (Rx), & Region (NA, Europe, APAC) - Global Forecast to 2026
The global prostate health market growth is primed to transition from USD 31.8 billion in 2021 to USD 48.9 billion by 2026, showcasing a strong CAGR of 9.0%. Growth in this market is primarily driven by the increasing prevalence of benign prostatic hyperplasia, increasing obesity, investments, funds, and grants for research in prostate health, an increase in the prevalence of prostate cancer, a surge in demand for hormone therapy drugs, emerging therapies for prostate cancer, and an increasing incidence of prostatitis.
- Published: December 2021
- Price: $ 4950
- TOC Available:
-
Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End-use Industry, Health/Functional Positioning, Distribution Channel, and Region - Global Forecast to 2031
The precision biotics market is estimated at USD 4.91 billion in 2026 and is projected to reach USD 9.26 billion by 2031, at a CAGR of 13.5% from 2026 to 2031. The report profiles key players such as BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)-(Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), and Infinant Health Inc (US).
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Patient Engagement Solutions Market by Therapy (Chronic [Obesity, Diabetes], Women’s Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing), End User (Hospital, ASC, Payer, Patient), Unmet Need, Investment - Forecast to 2030
The Asia Pacific Patient Engagement Solutions market, valued at USD 3.45 billion in 2024, stood at USD 3.97 billion in 2025 and is projected to advance at a resilient CAGR of 13.5% from 2025 to 2030, culminating in a forecasted valuation of USD 7.48 billion by the end of the period. This growth is driven by the rising demand for patient-centered and personalized care, a rapid expansion of telehealth and remote care frameworks, and more investments in digital healthcare infrastructure within the Asia Pacific region.
- Published: August 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
